CLIENT RESULT

Synthetic mRNA Production Landscape Assessment

Client INDUSTRY
Pharma
Stakeholder Interviews
12
mRNA Clinical Trials Analyzed
84
Biopharma Companies Profiled
21
Project Details
capability
Voice-of-Customer Research
capability
Competitive Analysis
capability
Market Landscaping and Sizing

Objective

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Our Approach

Secondary Research

  • Reviewed the therapeutic mRNA space and market demand for manufacturing
  • Summarized the key specifications required and demand drivers for external manufacturing
  • Assessed the CMO competitive landscape

‍Primary Research

  • Conducted 12 in-depth stakeholder interviews with biopharma experts who had direct experience synthesizing and using mRNA for therapeutic applications
  • Interviewees spanned public and private biopharma and covered a diverse range of therapeutic applications

Quantitative Analysis

  • Built a bottoms-up model estimating biopharma demand for and production of synthetic mRNA, at base year and five years forward, segmented by application area and phase of development

Outcome

DeciBio shared research findings with the client, including:

  • Estimated opportunity for external mRNA manufacturing at base year and five years forward
  • Outlined customer requirements, key considerations, and recommendations to help inform the client’s acquisition strategy

‍

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch